SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-16-116232
Filing Date
2016-04-29
Accepted
2016-04-29 16:31:17
Documents
4
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a16-9910_110ka.htm 10-K/A 769074
2 EX-31.3 a16-9910_1ex31d3.htm EX-31.3 13193
3 EX-31.4 a16-9910_1ex31d4.htm EX-31.4 12836
4 EX-32.2 a16-9910_1ex32d2.htm EX-32.2 7724
  Complete submission text file 0001104659-16-116232.txt   803940
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36306 | Film No.: 161607104
SIC: 2834 Pharmaceutical Preparations